ViiV CEO: "We Aim To Be Top HIV Player By Mid-2020s"

 
• By Sten Stovall

ViiV CEO predicts strong pipeline and two-drug strategy will reinforces group's HIV market position and put it ahead of Gilead by the mid-2020s.

HIV
ViiV Says Two-Drug Combo Strategy Will Make It Top HIV Player • Source: Shutterstock

More from Strategy

More from Business